Doxazosin Mesylate & Bladder transitional cell carcinoma
25.8%
of users reported Bladder transitional cell carcinoma
57.5%
also reported Hospitalization
100.0%
are women
Most common medical consequences
Hospitalization
57.5%
Severe reaction
42.5%
Have you experienced any negative side effects from this medication?
Doxazosin Mesylate: general information
Most common side effects (8)
Most commonly affected ages
60 - 69 years
37.0%
70 - 79 years
53.1%
80 - 89 years
10.0%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox